Search Results - "Renzo, Maria Flavia Di"
-
1
ERα as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells
Published in Proceedings of the National Academy of Sciences - PNAS (05-05-2009)“…Estrogen receptor α (ERα) and E-cadherin are primary markers of luminal epithelial breast cancer cells with E-cadherin being a main caretaker of the epithelial…”
Get full text
Journal Article -
2
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining
Published in NPJ systems biology and applications (05-01-2021)“…Single-cell RNA sequencing (scRNAseq) is an essential tool to investigate cellular heterogeneity. Thus, it would be of great interest being able to disclose…”
Get full text
Journal Article -
3
Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis
Published in Cancer research (Chicago, Ill.) (15-11-2010)“…Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is caused by mutations in the Krebs cycle enzyme fumarate hydratase (FH). It has been proposed that…”
Get full text
Journal Article -
4
Overexpression of the RON gene in human breast carcinoma
Published in Oncogene (04-06-1998)“…Constitutive activation of the RON gene, known to code for the tyrosine-kinase receptor for Macrophage Stimulating Protein (also known as Scatter Factor 2),…”
Get full text
Journal Article -
5
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs
Published in European journal of cancer (1990) (01-06-2016)“…Abstract Background Platinum drugs are the most powerful chemotherapeutic agents in the treatment of ovarian cancer. We demonstrated previously that…”
Get full text
Journal Article -
6
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
Published in International journal of molecular sciences (21-05-2022)“…The oncogene encodes a tyrosine kinase (TK) receptor. Its activation protects cells from death but also stimulates DNA damage response by triggering excess…”
Get full text
Journal Article -
7
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor
Published in International journal of cancer (15-03-2014)“…The hepatocyte growth factor (HGF) also known as scatter factor activates cancer cell invasion and metastasis. We show that in ovarian cancer cells HGF induced…”
Get full text
Journal Article -
8
Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
Published in Clinical cancer research (15-05-2011)“…We determined the gene copy numbers for MET, for its transcriptional activator MACC1 and for its ligand hepatocyte growth factor (HGF) in liver metastases from…”
Get full text
Journal Article -
9
CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2
Published in Journal of bone and mineral research (01-05-2014)“…ABSTRACT Differentiation therapy is an attractive treatment for osteosarcoma (OS). CD99 is a cell surface molecule expressed in mesenchymal stem cells and…”
Get full text
Journal Article -
10
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
Published in Journal of ovarian research (13-02-2019)“…Relapsed epithelial ovarian cancer (EOC) is frequently treated with pegylated liposomal doxorubicin (PLD). Unfortunately, most patients do not benefit from…”
Get full text
Journal Article -
11
Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism
Published in Molecular and Cellular Biology (01-08-2012)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-src activity and met signaling
Published in Cancer research (Chicago, Ill.) (15-08-2007)“…Caveolin-1 (Cav-1) is highly expressed in normal osteoblasts. This article reports that Cav-1 down-regulation is part of osteoblast transformation and…”
Get full text
Journal Article -
13
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer
Published in Oncotarget (03-05-2016)“…Platinum-based chemotherapy is the recommended first-line treatment for high-grade serous (HGS) epithelial ovarian cancer (EOC). However, most patients relapse…”
Get full text
Journal Article -
14
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma
Published in Cells (Basel, Switzerland) (14-02-2020)“…Identifying cancer drivers and actionable mutations is critical for precision oncology. In epithelial ovarian cancer (EOC) the majority of mutations lack…”
Get full text
Journal Article -
15
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer
Published in Cancer research (Chicago, Ill.) (01-02-2005)“…Companion animal spontaneous tumors are suitable models for human cancer, primarily because both animal population and the tumors are genetically…”
Get full text
Journal Article -
16
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging
Published in PloS one (19-03-2008)“…Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatment. Thus animal models are necessary to study the OSA metastatic spread…”
Get full text
Journal Article -
17
The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel In vivo
Published in Clinical cancer research (01-04-2007)“…Purpose: Advanced ovarian cancers are initially responsive to combinatorial chemotherapy with platinum drugs and taxanes but, in most cases, develop drug…”
Get full text
Journal Article -
18
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness
Published in Experimental cell research (15-08-2003)“…RON is a member of the receptor tyrosine kinase gene family that includes the MET oncogene, whose germline mutations have been causally related to human…”
Get full text
Journal Article -
19
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression
Published in Cancer research (Chicago, Ill.) (01-08-2004)“…RON is a tyrosine kinase receptor that triggers scattering of normal cells and invasive growth of cancer cells on ligand binding. We identified a short RON…”
Get full text
Journal Article -
20
A cancer‐predisposing “hot spot” mutation of the fumarase gene creates a dominant negative protein
Published in International journal of cancer (15-02-2008)“…The Fumarase (Fumarate Hydratase, FH) is a tumor suppressor gene whose germline heterozygous mutations predispose to hereditary leiomyomatosis and renal cell…”
Get full text
Journal Article